ARMATA PHARMACEUTICALS INC (ARMP) Stock Balance Sheet
NYSEARCA:ARMP - NYSE Arca - US04216R1023 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 11.69M | 9.29M | 13.52M | 14.85M | 10.29M | |||
| Receivables | 238.00K | 744.00K | 3.36M | N/A | N/A | |||
| Other Current Assets | 1.24M | 1.27M | 2.27M | 12.20M | 4.71M | |||
| Total Current Assets | 13.17M | 11.31M | 19.15M | 27.05M | 15.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 53.97M | 54.93M | 57.28M | 46.65M | 38.07M | |||
| Goodwill | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | |||
| Intangibles | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | |||
| Other Non-Current Assets | 6.37M | 6.46M | 8.19M | 8.39M | 2.96M | |||
| Total Non-Current Assets | 74.08M | 75.13M | 79.21M | 68.78M | 54.77M | |||
| TOTAL ASSETS | 87.25M | 86.44M | 98.36M | 95.83M | 69.77M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 27.69M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 75.09M | 38.95M | N/A | N/A | N/A | |||
| Accrued Expenses | 6.44M | 7.17M | 11.33M | 20.55M | 3.15M | |||
| Accounts Payable | 981.00K | 1.59M | 4.61M | 4.33M | 1.67M | |||
| Other Current Liabilities | 337.00K | 529.00K | 523.00K | N/A | 0.00 | |||
| Total Current Liabilities | 110.54M | 48.25M | 16.46M | 24.87M | 4.81M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 55.44M | 82.31M | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | |||
| Other Non-Current Liabilities | 27.42M | 27.69M | 28.58M | 31.80M | 36.48M | |||
| Total Non-Current Liabilities | 30.49M | 86.21M | 113.97M | 34.88M | 39.56M | |||
| TOTAL LIABILITIES | 141.03M | 134.46M | 130.43M | 59.75M | 44.37M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -334.27M | -327.74M | -308.82M | -239.77M | -202.86M | |||
| Additional Paid In Capital | 280.12M | 279.35M | 276.39M | 275.49M | 227.98M | |||
| Common Shares | 362.00K | 362.00K | 361.00K | 360.00K | 270.00K | |||
| Shares Outstanding | 36.19M | 36.18M | 36.12M | 36.14M | 27.11M | |||
| Tangible Book Value per Share | -1.87 | -1.71 | -1.27 | 0.62 | 0.43 | |||
| Total Shareholders' Equity | -53.78M | -48.02M | -32.06M | 36.08M | 25.40M | |||
| TOTAL LIABILITIES AND EQUITY | 87.25M | 86.44M | 98.36M | 95.83M | 69.77M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -1.15 | -2.57 | N/A | N/A | |||
| Current Ratio | 0.12 | 0.23 | 1.16 | 1.09 | 3.12 | |||
| Return On Assets (ROA) | -0.49% | -21.88% | -70.19% | -38.53% | -33.19% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -102.33% | -91.18% | |||
All data in USD , ROIC based on taxRate of 0.21